What is rheumatoid arthritis, its risk factors, manifestations, diagnosis, and differential diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rheumatoid Arthritis: Definition, Pathophysiology, Risk Factors, Manifestations, and Diagnosis

Rheumatoid arthritis (RA) is a chronic, progressive autoimmune disease characterized by symmetric inflammation of synovial joints, leading to cartilage damage, bone erosions, and joint destruction if not diagnosed early and treated aggressively. 1, 2

Definition and Pathophysiology

Rheumatoid arthritis is a systemic autoimmune inflammatory disorder that:

  • Affects approximately 1% of the general population 3
  • Involves inflammation primarily in synovial joints 1
  • Results from dysregulated immune responses where the body's immune system attacks its own tissues
  • Leads to synovitis (inflammation of the synovial membrane) which, if untreated, progresses to cartilage damage and bone erosions 3, 4
  • Involves complex inflammatory cascades with pro-inflammatory cytokines (TNF-α, IL-6) playing key roles in joint destruction 4

Risk Factors

Several factors increase the risk of developing RA:

  • Demographic factors:

    • Female sex (women are 2-3 times more likely to develop RA)
    • Older age 5
  • Genetic factors:

    • Family history of RA
    • Presence of HLA-DR4 and other HLA-DRB1 alleles 2
  • Environmental factors:

    • Smoking (strongest environmental risk factor)
    • Periodontal disease
    • Certain infections that may trigger autoimmunity
  • Serological factors:

    • Presence of rheumatoid factor (RF)
    • Anti-citrullinated protein antibodies (ACPA/anti-CCP) 2

Clinical Manifestations

RA presents with both articular and extra-articular manifestations:

Articular Manifestations:

  • Joint symptoms:
    • Symmetric polyarthritis (affecting multiple joints on both sides of the body)
    • Morning stiffness lasting >30 minutes
    • Pain, swelling, and tenderness of affected joints
    • Commonly affects small joints of hands and feet, particularly MCP, PIP joints, and wrists 1
    • Progressive joint deformities (boutonnière deformity, swan-neck deformity, ulnar deviation)

Extra-articular Manifestations:

  • Rheumatoid nodules
  • Cardiovascular disease (increased risk of myocardial infarction and stroke)
  • Pulmonary involvement (interstitial lung disease, pleural effusions)
  • Ocular manifestations (scleritis, episcleritis)
  • Hematologic abnormalities (anemia of chronic disease, thrombocytosis)
  • Neurological manifestations (peripheral neuropathy, mononeuritis multiplex)
  • Felty's syndrome (RA, splenomegaly, neutropenia)

Differential Diagnosis

Consider these conditions when evaluating a patient with suspected RA:

  • Other inflammatory arthritides:

    • Psoriatic arthritis
    • Systemic lupus erythematosus
    • Spondyloarthropathies (ankylosing spondylitis, reactive arthritis)
    • Inflammatory osteoarthritis
  • Crystal-induced arthropathies:

    • Gout
    • Calcium pyrophosphate deposition disease (pseudogout)
  • Infectious arthritis:

    • Viral arthritis (parvovirus, hepatitis)
    • Bacterial arthritis
    • Lyme disease
  • Other conditions:

    • Polymyalgia rheumatica
    • Sarcoidosis
    • Paraneoplastic syndromes

Diagnosis

The diagnosis of RA relies on a combination of clinical, laboratory, and imaging findings:

Clinical Assessment:

  • Evaluate joint involvement pattern (symmetric, polyarticular)
  • Assess duration of symptoms (persistent synovitis)
  • Document morning stiffness 2

Laboratory Testing:

  • Autoantibodies:

    • Rheumatoid factor (RF) - offer to all patients with suspected RA who have synovitis 1
    • Anti-citrullinated protein antibodies (ACPA/anti-CCP) - consider if RF negative 1, 2
    • Antinuclear antibodies (ANA) - for suspected overlap syndromes 2
  • Inflammatory markers:

    • Erythrocyte sedimentation rate (ESR)
    • C-reactive protein (CRP) 2
  • Other laboratory tests:

    • Complete blood count (CBC) - may show anemia of chronic disease
    • Liver and kidney function tests - baseline before starting treatment
    • Uric acid - to rule out gout 2

Imaging:

  • Conventional radiography:

    • First-line imaging modality
    • May show periarticular osteopenia, joint space narrowing, erosions
    • Limited sensitivity for early disease 2
  • Ultrasound:

    • Superior to clinical examination for detecting synovitis
    • Can detect subclinical inflammation 2
  • MRI:

    • More sensitive than conventional radiography for early erosions
    • Can detect bone edema, a predictor of radiographic progression 2

Diagnostic Criteria:

The American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) 2010 classification criteria are used for diagnosing RA, based on:

  1. Joint involvement (0-5 points)
  2. Serology (0-3 points)
  3. Acute phase reactants (0-1 point)
  4. Duration of symptoms (0-1 point)

A score of ≥6/10 indicates definite RA 2

Common Pitfalls in Diagnosis

  • Delaying referral to a rheumatologist (should be within 6 weeks of symptom onset)
  • Overlooking RA in patients with only one or few affected joints initially
  • Assuming that hand stiffness in older adults is always due to osteoarthritis 2
  • Waiting for positive RF before referral (refer urgently even with normal acute-phase response or negative RF) 1

Key Points for Early Diagnosis

  • Refer for specialist opinion anyone with suspected persistent synovitis of undetermined cause
  • Refer urgently if:
    • Small joints of hands or feet are affected
    • More than one joint is affected
    • Symptoms have persisted for ≥3 months 1

Early diagnosis and aggressive treatment are crucial to prevent joint damage, preserve function, and prevent disability in patients with RA 3, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cervical Arthritis Related to Autoimmune Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.